BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression

Front Endocrinol (Lausanne). 2024 Dec 9:15:1440722. doi: 10.3389/fendo.2024.1440722. eCollection 2024.

Abstract

Introduction: BRAFV600E mutation (BRAFmut) is common in papillary thyroid cancer (PTC), and most patients have an excellent outcome. However, a TERT-promoter mutation (pTERTmut) in the presence of BRAFmut (BRAFmutpTERTmut) has been demonstrated to confer a more aggressive behavior to PTC. Lymphocytic infiltration is often present in PTC. In this study, we sought to decipher the relationship between the BRAF and pTERT mutations and immune gene dysregulation in tumor samples from a cohort of 147 samples of PTC.

Methods: The abundance of 770 immune gene transcripts was determined by multiprex capture/detection and digital counting of mRNA transcripts using the NanoString nCounter® PanCancer Immune Profiling Panel.

Results: We identified 40 immune transcripts differentially expressed in BRAFmutpTERTmut vs BRAFmutpTERT wildtype (pTERTwt) (P<0.05). Transcripts induced by BRAFmut alone were significantly repressed in BRAFmutpTERTmut samples, such as genes expressed by lymphoid cells, antigen-presenting cells, and cytotoxic cells, including chemokines, cytokines, checkpoint control proteins, interferon downstream markers, TNF superfamily proteins and BMP markers. A validation analysis using 444 samples from The Cancer Genome Atlas (TCGA) PTC dataset yielded similar results. Deconvolution analysis confirmed differences in the immune cell populations such as increased presence of M2 macrophages in the BRAFmutpTERTmut Mayo cohort and a lower abundance of M1 macrophages in the BRAFmutpTERTmut TCGA cohort compared to BRAFmutpTERTwt. Most of the immune gene pathways were enriched in the BRAFmutpTERTwt tumors in both Mayo and TCGA cohorts but not in BRAFmutpTERTmut. BRAFmutpTERTwt had higher stromal lymphocytes infiltration as compared to BRAFwtpTERTwt tumors, corroborating the transcriptomic findings.

Discussion: To our knowledge this is the first report of a potential link between TERT and the immune microenvironment, offering an explanation for the aggressive nature of BRAFmutpTERTmut PTC.

Keywords: BRAF mutation V600 E; TERT promoter mutation (pTERT); immune genes; lymphocytic infiltration; papillary thyroid cancer (PTC).

MeSH terms

  • Adult
  • Aged
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Promoter Regions, Genetic
  • Proto-Oncogene Proteins B-raf* / genetics
  • Telomerase* / genetics
  • Thyroid Cancer, Papillary* / genetics
  • Thyroid Cancer, Papillary* / immunology
  • Thyroid Cancer, Papillary* / pathology
  • Thyroid Neoplasms* / genetics
  • Thyroid Neoplasms* / immunology
  • Thyroid Neoplasms* / pathology
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology

Substances

  • Proto-Oncogene Proteins B-raf
  • BRAF protein, human
  • TERT protein, human
  • Telomerase

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Mayo Clinic’s Center for Clinical and Translational Science and Team Science Pilot award, the Georg Haub Family Career Development Award in Cancer Research Honoring Richard F. Emslander and Mayo Clinic Comprehensive Cancer Center.